ZA202300128B - A composition for management of covid-19 and associated disorders - Google Patents

A composition for management of covid-19 and associated disorders

Info

Publication number
ZA202300128B
ZA202300128B ZA2023/00128A ZA202300128A ZA202300128B ZA 202300128 B ZA202300128 B ZA 202300128B ZA 2023/00128 A ZA2023/00128 A ZA 2023/00128A ZA 202300128 A ZA202300128 A ZA 202300128A ZA 202300128 B ZA202300128 B ZA 202300128B
Authority
ZA
South Africa
Prior art keywords
composition
present disclosure
covid
management
associated disorders
Prior art date
Application number
ZA2023/00128A
Inventor
Prakash Pundlik Salunke
Vaisahli Prakash Salunke
Pravin Ekanath Patil
Original Assignee
Vedicinals India Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2021/054727 external-priority patent/WO2021240481A2/en
Application filed by Vedicinals India Private Ltd filed Critical Vedicinals India Private Ltd
Publication of ZA202300128B publication Critical patent/ZA202300128B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.
ZA2023/00128A 2020-05-29 2023-01-03 A composition for management of covid-19 and associated disorders ZA202300128B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202021022638 2020-05-29
PCT/IB2021/054727 WO2021240481A2 (en) 2020-05-29 2021-05-29 A composition for management of covid-19 and associated disorders

Publications (1)

Publication Number Publication Date
ZA202300128B true ZA202300128B (en) 2023-12-20

Family

ID=89324813

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2023/00128A ZA202300128B (en) 2020-05-29 2023-01-03 A composition for management of covid-19 and associated disorders

Country Status (1)

Country Link
ZA (1) ZA202300128B (en)

Similar Documents

Publication Publication Date Title
PH12018502438A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
BR112014009851A2 (en) nmda receptor modulators and uses thereof
MX2009009623A (en) Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors.
PH12019500208A1 (en) Spiro-lactam nmda receptor modulators and methods of using same
PH12019500202A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
BRPI0918868B8 (en) nmda receptor modulating compounds and compositions comprising the same
PH12019500207A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MX2019001322A (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof.
MX2019001321A (en) Spiro-lactam nmda receptor modulators and uses thereof.
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
MX2021010058A (en) Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders.
EP2490700A4 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
PH12020551555A1 (en) Calpain modulators and therapeutic uses thereof
MX2020010879A (en) Bicyclic carboxamides and methods of use thereof.
WO2005117940A3 (en) Cell death modulation via antagonists of fasl and fas activation
WO2004093995A3 (en) Use of antioxidants to treat bone loss disorders
MX2020009942A (en) Compounds and uses thereof.
MX2022001952A (en) Alkynyl quinazoline compounds.
ZA202300128B (en) A composition for management of covid-19 and associated disorders
MX2023003675A (en) Hsd17b13 inhibitors and uses thereof.
WO2021240481A3 (en) A composition for management of covid-19 and associated disorders
MX2022005388A (en) Pyrrolidine and piperidine compounds.
SE1750680A1 (en) Composition for treating or preventing climacteric disorders
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
RU2011113733A (en) Derivatives of 1-amino-alkylcyclohexane for the treatment of cognitive impairment in noise in the ears